 | Up a level |
Number of items: 1.
Johnson, Melissa Lynne, Doroshow, Deborah Blythe, Seiwert, Tanguy Y., Gibson, Michael K., Velcheti, Vamsidhar, Lisberg, Aaron Elliott, Patel, Shetal Arvind, Scheffler, Matthias, Lafleur, Francois, Dugan, Margaret Han and Sharma, Sunil (2021). Phase 1 and phase 2a, first-in-human (FIH) study, of DRP-104, a broad glutamine antagonist, in adult patients with advanced solid tumors. J. Clin. Oncol., 39 (15). PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1527-7755